Unfortunately, we consider that no firm conclusions can be drawn with regard to the relationship between baseline or IFN-induced miRNA expression and the clinical outcome of IFN alpha therapy in patients with CHC. The gene discussed is IFNA1; the disease is cryohydrocytosis.